Invesaro

Stocks Comparison

Franklin Covey vs Rentokil Initial: revenue, profit, margins and growth compared

Franklin Covey brought in $267.1M of revenue in fiscal 2025, Rentokil Initial $6.9B in fiscal 2025. Revenue changed by -7.0% at Franklin Covey and +4.4% at Rentokil Initial on the year before, so Rentokil Initial grew faster. Franklin Covey kept 1.1% of its revenue as net profit, Rentokil Initial 6.8%. Free cash flow was $20.7M at Franklin Covey and $764M at Rentokil Initial.

Side by side, latest fiscal year

FCRTO
Fiscal year endedFY2025 (August 31, 2025)FY2025 (December 31, 2025)
Revenue$267.1M$6.9B
Revenue growth-7.0%+4.4%
Net income$3.1M$470M
Net margin1.1%6.8%
Free cash flow$20.7M$764M
Free cash flow margin7.8%11.1%
Earnings per share (diluted)$0.24$0.19
Cash$31.7M$2.3B
Debtn/a$5.4B
Price to earnings70.6n/a
Market value$191.4M$10.3B
Dividend yieldn/an/a
Rank by revenue in sector#673 of 1065 · Consumer discretionary#168 of 1065 · Consumer discretionary

Over the years

Revenue
FC FY2018: $209.8MFC FY2019: $225.4MFC FY2020: $198.5MFC FY2021: $224.2MFC FY2022: $262.8MFC FY2023: $280.5MFC FY2024: $287.2MFC FY2025: $267.1MRTO FY2023: $6.4BRTO FY2025: $6.6BRTO FY2025: $6.9BFY18FY19FY20FY21FY22FY23FY24FY25
FC $267.1MRTO $6.9B
Net income
FC FY2018: -$5.9MFC FY2019: -$1MFC FY2020: -$9.4MFC FY2021: $13.6MFC FY2022: $18.4MFC FY2023: $17.8MFC FY2024: $23.4MFC FY2025: $3.1MRTO FY2023: $474MRTO FY2025: $392MRTO FY2025: $470MFY18FY19FY20FY21FY22FY23FY24FY25
FC $3.1MRTO $470M
Net margin
FC FY2018: -2.8%FC FY2019: -0.5%FC FY2020: -4.8%FC FY2021: 6.1%FC FY2022: 7.0%FC FY2023: 6.3%FC FY2024: 8.1%FC FY2025: 1.1%RTO FY2023: 7.4%RTO FY2025: 5.9%RTO FY2025: 6.8%FY18FY19FY20FY21FY22FY23FY24FY25
FC 1.1%RTO 6.8%
Revenue growth
FC FY2019: +7.4%FC FY2020: -11.9%FC FY2021: +13.0%FC FY2022: +17.3%FC FY2023: +6.7%FC FY2024: +2.4%FC FY2025: -7.0%RTO FY2025: +3.6%RTO FY2025: +4.4%FY19FY20FY21FY22FY23FY24FY25
FC -7.0%RTO +4.4%
Free cash flow
FC FY2018: $10.3MFC FY2019: $26.3MFC FY2020: $23.4MFC FY2021: $44.6MFC FY2022: $49.1MFC FY2023: $31.2MFC FY2024: $56.6MFC FY2025: $20.7MRTO FY2023: $709MRTO FY2025: $649MRTO FY2025: $764MFY18FY19FY20FY21FY22FY23FY24FY25
FC $20.7MRTO $764M

Fiscal years as each company reports them; the two may end in different months.

Questions about Franklin Covey and Rentokil Initial

Which is bigger by revenue, Franklin Covey or Rentokil Initial?

Rentokil Initial is bigger by revenue: $6.9B in fiscal 2025, against $267.1M for Franklin Covey in fiscal 2025.

Which keeps more of its revenue as profit, Franklin Covey or Rentokil Initial?

Franklin Covey had a net margin of 1.1% in fiscal 2025; Rentokil Initial had 6.8% in fiscal 2025.

Which grew revenue faster, Franklin Covey or Rentokil Initial?

In their latest fiscal years revenue changed by -7.0% at Franklin Covey and +4.4% at Rentokil Initial.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies